PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Oct-2021 Celyad Oncology to Present New Data on Allogeneic CAR T Therapy Program at the Society for Immunotherapy of Cancer Annual Meeting Businesswire
01-Oct-2021 Global Drug Discovery Technologies Market Expected to Grow at a CAGR of 6% Between 2021 and 2030 - ResearchAndMarkets.com Businesswire
01-Oct-2021 Heidelberg Pharma AG Announces Adjustment of Guidance Heidelberg Pharma AG
01-Oct-2021 Gallenkamp Launches Smart New Website and Brochure Gallenkamp
01-Oct-2021 Why do some people get Covid worse than others? Expert reveals breakthrough research London Medical Laboratory
01-Oct-2021 New, late-breaking data at EADV highlights emerging clinical profile of amlitelimab (formerly KY1005) in adults with inadequately controlled moderate-to-severe atopic dermatitis Sanofi
01-Oct-2021 Ynvisible Interactive to Participate in Upcoming Investor Conferences Businesswire
01-Oct-2021 Covid-19 Pandemic Is Likely To Augment Demand Of Wound Healing Supplement Market MARKITWIRED Latest Market Reports
01-Oct-2021 Novartis data show rapid and effective disease activity control with remibrutinib (LOU064) in patients with chronic spontaneous urticaria Novartis
01-Oct-2021 Increasing Inner Ear Disorders Is Likely To Boost Demand For Electronystagmography Testing Market MARKITWIRED Latest Market Reports
01-Oct-2021 Worldwide Flexible Intermediate Bulk Container Industry to 2026 - Featuring Berry Global, Bulk Lift International and Greif Among Others - ResearchAndMarkets.com Businesswire
01-Oct-2021 Santhera will Publish its Interim Report for the First Half of 2021 on October 15, 2021 Santhera
01-Oct-2021 Rapid Dose Therapeutics Receives Cannabis Sales License from Health Canada Businesswire
01-Oct-2021 NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research Businesswire
01-Oct-2021 European Medicines Agency Validates Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as First-Line Treatment for Patients with Unresectable or Metastatic Melanoma Businesswire
01-Oct-2021 Cybin Announces Appointment of Dr. Amir Inamdar as Chief Medical Officer for European Operations and Dr. Geoff Varty as the Head of Research and Development Businesswire
01-Oct-2021 Compass Therapeutics and ABL Bio Announce Presentation of CTX-009 Clinical Data as a Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Businesswire
01-Oct-2021 Enanta Pharmaceuticals Announces Data Presentations at AASLD’s The Liver Meeting® 2021 Businesswire
01-Oct-2021 Atlas Venture Announces $300 Million Second Opportunity Fund Businesswire
01-Oct-2021 European Medicines Agency Validates Bristol Myers Squibb’s Application for Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy Businesswire